Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04480502
Title ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma (ENVASARC)
Acronym ENVASARC
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | GBR


No variant requirements are available.